Genmab — Juli 2019
-
a few articles on Teprotumumab “Patients’ quality of life can suffer significantly due to this disease. It causes them to look different and they often withdraw from almost all of their social activity and avoid leaving the house. This drug is a game changer.” https://www.endocrineweb.com/professional/thyroid-disorders/breakthrough-treatment-management-graves-thyroid-eye-disease
-
Horizon expects to have hired most of its sales reps for teprotumumab by the end of July https://www.fiercepharma.com/marketing/horizon-bulks-up-salesforce-ahead-750m-inflammatory-eye-drug-launch
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind